It Only Takes One
campaign against the fentanyl and opioid crisis
First Lady Suzanne S. Youngkin and Attorney General Jason Miyares announced the launch of the Fentanyl Awareness Pilot Program at the Fralin Biomedical Research Institute in Roanoke, VA.
The first-of-its-kind, Virginia Department of Health awareness initiative is being implemented with support from the First Lady of Virginia and the Virginia Foundation for Healthy Youth (VFHY) in partnership with Attorney General Miyares’ ‘One Pill Can Kill’ campaign.
The campaign strives to warn parents and caregivers that “it only takes one.” One bad decision, one counterfeit pill can cost a life. An average of five Virginians die from fentanyl poisoning every day, becoming the leading cause of unnatural death in the Commonwealth. Since 2019, deaths have more than doubled in the Roanoke region.
It's not a matter of IF...
Download, print and share!
2024 It Only Takes One flyer
News highlights around the web
Suzanne Youngkin, the first lady of Virginia, is leading a new public fight against fentanyl, an extremely dangerous and deadly synthetic opioid.
In Roanoke today, Attorney General Jason Miyares and First Lady Suzanne S. Youngkin launched a fentanyl awareness campaign at the Fralin Biomedical Research Institute.
Every day five Virginians will die of fentanyl poisoning, according to the State’s Department of Health.
Virginia First Lady Suzanne Youngkin and Attorney General Jason Miyares came to Roanoke Tuesday to launch a campaign to tackle the fentanyl and opioid crisis. It aims to bring awareness to the dangers of fentanyl.
Fentanyl is the focus of a statewide drug awareness campaign that Virginia first lady Suzanne Youngkin launched Tuesday in Roanoke.
Virginia first lady Suzanne Youngkin will be announcing on Tuesday a pilot program for dealing with the fentanyl epidemic in the commonwealth, focusing on education and support resources to prevent overdose deaths.
First Lady Suzanne S. Youngkin and Attorney General Jason Miyares announced the launch of their Fentanyl Awareness Pilot Program at the Fralin Biomedical Research Institute in Roanoke, VA.